As of May 27
| +0.01 / +0.67%|
The 1 analysts offering 12-month price forecasts for Acasti Pharma Inc have a median target of 14.90, with a high estimate of 14.90 and a low estimate of 14.90. The median estimate represents a +893.48% increase from the last price of 1.50.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.